MedPath

HERZUMA

These highlights do not include all the information needed to use HERZUMA safely and effectively. See full prescribing information for HERZUMA. HERZUMA (trastuzumab-pkrb) for injection, for intravenous use Initial U.S. Approval: 2018 HERZUMA (trastuzumab-pkrb) is biosimilar to HERCEPTIN (trastuzumab).

Approved
Approval ID

ae71c003-883a-4cd8-ad50-e8cc9a54e971

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 6, 2023

Manufacturers
FDA

Cephalon, Inc.

DUNS: 183236314

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

TRASTUZUMAB

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code63459-303
Application NumberBLA761091
Product Classification
M
Marketing Category
C73585
G
Generic Name
TRASTUZUMAB
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateFebruary 6, 2023
FDA Product Classification

INGREDIENTS (5)

TRASTUZUMABActive
Quantity: 150 mg in 7.15 mL
Code: P188ANX8CK
Classification: ACTIB
TREHALOSE DIHYDRATEInactive
Quantity: 299.6 mg in 7.15 mL
Code: 7YIN7J07X4
Classification: IACT
HISTIDINEInactive
Quantity: 2.2 mg in 7.15 mL
Code: 4QD397987E
Classification: IACT
POLYSORBATE 20Inactive
Quantity: 0.6 mg in 7.15 mL
Code: 7T1F30V5YH
Classification: IACT
HISTIDINE MONOHYDROCHLORIDEInactive
Quantity: 3.4 mg in 7.15 mL
Code: 1D5Q932XM6
Classification: IACT

TRASTUZUMAB

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code63459-305
Application NumberBLA761091
Product Classification
M
Marketing Category
C73585
G
Generic Name
TRASTUZUMAB
Product Specifications
Effective DateFebruary 6, 2023
FDA Product Classification

Drug Labeling Information

INDICATIONS & USAGE SECTION

LOINC: 34067-9Updated: 12/11/2024

DRUG INTERACTIONS SECTION

LOINC: 34073-7Updated: 12/11/2024

NONCLINICAL TOXICOLOGY SECTION

LOINC: 43680-8Updated: 11/25/2024

INFORMATION FOR PATIENTS SECTION

LOINC: 34076-0Updated: 12/11/2024

SPL UNCLASSIFIED SECTION

LOINC: 42229-5Updated: 8/28/2024

DOSAGE & ADMINISTRATION SECTION

LOINC: 34068-7Updated: 12/11/2024

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.